Indicated for: cognitive disorders; cerebral circulatory disorders
Route of administration: oral
Substance: vinpocetine (cerebral metabolic agent)
ATC: N06BX18 (Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics)
Vinpocetine is a medication used to improve cerebral circulation and cognitive function, particularly in patients with neurological or vascular disorders such as vascular dementia or ischemic stroke. It is a semisynthetic derivative of vincamine, an alkaloid extracted from the Vinca minor plant, and works by increasing cerebral blood flow and enhancing oxygen utilization by the brain.
Vinpocetine is administered orally or intravenously, depending on the severity of the condition and the physician's recommendations. Treatment is usually long-term, and the dosage is adjusted based on the patient's response.
Common side effects include nausea, dizziness, headaches, and gastrointestinal disturbances. In rare cases, severe adverse reactions such as hypotension or allergic reactions may occur.
Patients using vinpocetine should be regularly monitored for treatment efficacy and signs of adverse reactions. The medication is an effective option for improving cognitive function and quality of life in patients with cerebral circulatory disorders.